The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (13 analysts) rates it hold, with a mean price target of $86. It reported earnings in this window, a natural checkpoint for the thesis.
Lennar
LEN · a US exchange · USD · Market cap $19.5B · 12,532 employees
Lennar Corporation, together with its subsidiaries, operates as a homebuilder primarily under the Lennar brand in the United States.
PASS · Titan Ethical · score 89.5At the last full screen
2026-09-09
Screened 2026-09-09 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Lennar holds its Markdown at $80.76. Consolidating, no directional conviction, held for 2 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 2 days |
| Price at the screen | $80.76 |
| Valuation | 12.66 trailing · 12.59 forward price to earnings |
| Values screen | PASS · score 89.5 |
| Beta | 1.40 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 17.06% | Below 33% | Interest-bearing debt is just 17.1% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 1.01% | Below 33% | Cash held in interest-bearing accounts and securities is 1.0% of assets, under the one-third limit. | Pass |
| Receivables | 14.71% | Below 49% | Money owed to the company is 14.7% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads OPPORTUNITY: it trades above our $71.36 fair value estimate, narrow competitive moat.
Fair value range in USD, drawn from the 2026-09-09 screen. The gold marker is the market price at the same screen. The price runs 11.6% above the base estimate.
Third-party analyst targets: 13 covering, consensus Hold. The average target sits +5% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-09 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsHousing cycles punish thin returns fast
When mortgage rates stay high, families delay the biggest purchase of their lives and every extra unsold home sits on the builder's books. Lennar builds across the main US regions yet shows only a narrow edge, single digit returns on equity and revenue already falling 5%.
A forward multiple of 12.7 times looks modest until you see profit margins stuck at 5%. The opportunity rating and clean ethical screen do not change the fact that this remains a classic cyclical business where low multiples often flag peak earnings rather than bargains.
Analysts hold a neutral stance with targets barely above the current price. Any fresh drop in buyer demand would cut volumes and margins quickly. Analysis, not advice.
| Forward P/E | 12.6xreasonably valued |
| Trailing P/E | 12.7xreasonably valued |
| EPS, trailing | 6.38 |
| EPS, forward | 6.41 |
| Revenue growth | -5.2%revenue is shrinking |
| Profit margin | 4.9%barely profitable |
| Return on equity | 7.4%a modest return on shareholder capital |
| FCF yield | 5.54% |
| Dividend yield | 2.35% |
| Debt to equity | 0.29minimal debt: a conservative balance sheet |
| Current ratio | 8.51comfortably covers its short-term bills |
| Beta | 1.40moves a little more than the market |
| Short interest, float | 0.00% |
| 52-week range | 79.79 - 140.71 |
| Moat | NARROW |
| Market cap | $19.5B |
| Employees | 12,532 |
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeLEN trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (13 analysts) rates it hold, with a mean price target of $86. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 7.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (13 analysts) rates it hold, with a mean price target of $86. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (13 analysts) rates it hold, with a mean price target of $86. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.7% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (13 analysts) rates it hold, with a mean price target of $86.
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 3.1% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (13 analysts) rates it hold, with a mean price target of $89.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (13 analysts) rates it hold, with a mean price target of $89.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- 10 U.S. metro areas where builders are slashing prices on new homes MarketWatch · 17 Jul 2026
- 3 Stocks Smart Investors Are Buying in July 24/7 Wall St. · 17 Jul 2026
- Is Lennar’s (LEN) Urban Townhome Push Quietly Reshaping Its Asset-Light Strategy? Simply Wall St. · 15 Jul 2026
- Lennar (LEN) Launches New Communities, Is The Valuation Discount Already Deserved? Simply Wall St. · 14 Jul 2026
- Landmark Housing Affordability Bill Becomes Law: ETFs in Focus Zacks · 13 Jul 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-11 | MILLER STUART A. | Chief Executive Officer | 2,000 | · | |
| 2026-04-22 | MCCLURE TERI PLUMMER | Director | 12 | $1,133 | |
| 2026-04-22 | OLIVERA ARMANDO J | Director | 14 | $1,322 | |
| 2026-04-22 | BANSE AMY L | Director | 12 | $1,133 | |
| 2026-04-22 | HUDSON SHERRILL W | Director | 12 | $1,133 | |
| 2026-04-22 | SONNENFELD JEFFREY ALAN | Director | 13 | $1,228 | |
| 2026-04-22 | GILLIAM THERON I JR | Director | 12 | $1,133 | |
| 2026-04-22 | WOLFE SERENA | Director | 12 | $1,133 | |
| 2026-04-22 | SMITH DACONA | Director | 12 | $1,133 | |
| 2026-04-08 | MCCLURE TERI PLUMMER | Director | 2,313 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 7 Jul2026 | Ro Khanna | Democrat | sell | 1K–15K |
| 7 Jul2026 | Ro Khanna | Democrat | sell | 1K–15K |
| 7 Jul2026 | Ro Khanna | Democrat | sell | 1K–15K |
| 7 Feb2025 | Tim Walberg | Republican | buy | 1K–15K |
| 3 May2024 | Tommy Tuberville | Republican | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $87.09 | +2.8% | · | $1,028 | +2.8% |
| 2 months | $88.50 | +1.2% | $0.50 | $1,017 | +1.7% |
| 3 months | $92.05 | -2.7% | $0.50 | $978 | -2.2% |
| 6 months | $118.00 | -24.1% | $1.00 | $767 | -23.3% |
| 1 year | $111.49 | -19.7% | $2.00 | $821 | -17.9% |
| 2 years | $145.58 | -38.5% | $3.97 | $642 | -35.8% |
| 3 years | $105.60 | -15.2% | $5.66 | $902 | -9.8% |
| 5 years | $83.17 | +7.7% | $8.32 | $1,177 | +17.7% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever LEN does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.